ESC 365 - Concurrent light chain and transthyretin cardiac amyloidosis.

ESC Professional Premium Access

Concurrent light chain and transthyretin cardiac amyloidosis.

Session: Amyloidosis: diagnosis and management

Topic: Clinical

Speaker: Doctor C. Kanaan (Cleveland, US)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Christopher Kanaan

Cleveland Clinic Foundation, Cleveland (United States of America)

1 presentation

0 follower

4 more presentations in this session

Amyloidosis: diagnosis and management - Get ready for the session.

First degree atrioventricular block as an early predictor of advanced conduction system disease in Val 142Ile hereditary cardiac amiloydosis.

Speaker: Doctor N. S V Nunes (Niteroi, BR)

Two rare conditions on the same patient: AL cardiac amyloidosis in a female carrier of ATTR mutation (pval142ile) with a family history of heart failure at a young age.

Speaker: Associate Professor F. Guerra (Ancona, IT)

The successful treatment of a cardiogenic shock due to cardiac light chain (AL) amyloidosis.

Speaker: Doctor M. Fialova (Hradec Kralove, CZ)

Access the full session

Amyloidosis: diagnosis and management

Speakers: Doctor C. Kanaan, Doctor N. S V Nunes, Associate Professor F. Guerra, Doctor M. Fialova

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources